TRANSGENE BIOTEK LTD.
BSE: 526139
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 0.06+10.1% | 0.05+3.2% | 0.05+6.7% | 0.05-35.3% | 0.08-0.6% | 0.08+30.5% | 0.06 |
| Other Income | 0.00-100.0% | 0.15 | 0.00 | 0.00-100.0% | 0.04-0.5% | 0.04+0.0% | 0.04 |
| Total Income | 0.06-70.6% | 0.20+287.1% | 0.05+6.7% | 0.05-58.9% | 0.12+0.3% | 0.12+17.6% | 0.10 |
| EXPENSES | |||||||
| Expenditure | 0.45-32.1% | 0.66+49.9% | 0.44-8.7% | 0.48-42.0% | 0.83+298.8% | 0.21+18.8% | 0.18 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| PROFIT | |||||||
| PBT | -0.39+14.9% | -0.46-17.7% | -0.39+10.4% | -0.43+39.2% | -0.71-701.2% | -0.09-21.9% | -0.07 |
| Net Profit | -0.39+14.9% | -0.46-17.7% | -0.39+10.4% | -0.43+39.2% | -0.71-701.2% | -0.09-21.9% | -0.07 |
| KEY METRICS | |||||||
| OPM % | -97.00%+3.00pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-25.83pp | -74.17%-2.60pp | -71.57% |
| EPS | 0.05-16.7% | 0.06+20.0% | 0.05-16.7% | 0.06-33.3% | 0.09+1000.0% | -0.01+0.0% | -0.01 |
Corporate Events
Board MeetingTRABI
20267Aug
Board Meeting
The board meeting is scheduled to consider and approve the u…
BSE Filing ↗ Board MeetingTRABI
202613Feb
Board Meeting
Consider and approve Un-Audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingTRABI
202524Jan
Board Meeting
Consider and approve Un-Audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingTRABI
202430May
Board Meeting
Consider and approve Audited Financial Results (Standalone a…
BSE Filing ↗